110 related articles for article (PubMed ID: 25339030)
21. Krüppel-Like Factor 4 Inhibits Pancreatic Cancer Epithelial-to-Mesenchymal Transition and Metastasis by Down-Regulating Caveolin-1 Expression.
Zhu Z; Yu Z; Wang J; Zhou L; Zhang J; Yao B; Dou J; Qiu Z; Huang C
Cell Physiol Biochem; 2018; 46(1):238-252. PubMed ID: 29587259
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and prognostic value of S100A4 expression in gastric cancer: a meta-analysis.
Ling Z; Li R
Int J Biol Markers; 2014 Jun; 29(2):e99-e111. PubMed ID: 24242292
[TBL] [Abstract][Full Text] [Related]
23. Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses.
Barresi V; Giuffre' G; Vitarelli E; Todaro P; Tuccari G
Virchows Arch; 2008 Dec; 453(6):571-8. PubMed ID: 18936967
[TBL] [Abstract][Full Text] [Related]
24. Caveolin-1 Inhibits Proliferation, Migration, and Invasion of Human Colorectal Cancer Cells by Suppressing Phosphorylation of Epidermal Growth Factor Receptor.
Yang J; Zhu T; Zhao R; Gao D; Cui Y; Wang K; Guo Y
Med Sci Monit; 2018 Jan; 24():332-341. PubMed ID: 29339715
[TBL] [Abstract][Full Text] [Related]
25. Association of miR-193b down-regulation and miR-196a up-regulation with clinicopathological features and prognosis in gastric cancer.
Mu YP; Tang S; Sun WJ; Gao WM; Wang M; Su XL
Asian Pac J Cancer Prev; 2014; 15(20):8893-900. PubMed ID: 25374225
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value and Clinicopathological Differences of Bmi1 in Gastric Cancer: A Meta-analysis.
Yuan B; Zhao H; Xue X; Zhou J; Wang X; Han Y; Zhang L; Guo X; Zhi Q
Anticancer Agents Med Chem; 2016; 16(4):407-13. PubMed ID: 25968877
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
28. CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: a systematic review and meta-analysis.
Yiming L; Yunshan G; Bo M; Yu Z; Tao W; Gengfang L; Dexian F; Shiqian C; Jianli J; Juan T; Zhinan C
Oncotarget; 2015 Dec; 6(39):42019-27. PubMed ID: 26503471
[TBL] [Abstract][Full Text] [Related]
29. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and clinicopathological value of Gli-1 expression in gastric cancer: A meta-analysis.
Lu L; Wu M; Zhao F; Fu W; Li W; Li X; Liu T
Oncotarget; 2016 Oct; 7(42):69087-69096. PubMed ID: 27634907
[TBL] [Abstract][Full Text] [Related]
31. The association of Caveolin-1 genotypes with oral cancer susceptibility in Taiwan.
Bau DT; Tsai MH; Tsou YA; Wang CH; Tsai CW; Sun SS; Hua CH; Shyue SK; Tsai RY
Ann Surg Oncol; 2011 May; 18(5):1431-8. PubMed ID: 21246406
[TBL] [Abstract][Full Text] [Related]
32. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer.
Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X
J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of Metastatic Tumoral Caveolin-1 Expression in Patients with Resected Gastric Cancer.
Sun S; Hong SA; Won HS; Yoo SH; Lee HH; Kim O; Ko YH
Gastroenterol Res Pract; 2017; 2017():5905173. PubMed ID: 28828003
[TBL] [Abstract][Full Text] [Related]
34. Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism could be a risk factor for gastric cancer.
Zhao J; Zhi Z; Song G; Wang J; Wang C; Ma H; Yu X; Sui A; Zhang H
Asian Pac J Cancer Prev; 2015; 16(6):2333-40. PubMed ID: 25824760
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
Du ZM; Hu CF; Shao Q; Huang MY; Kou CW; Zhu XF; Zeng YX; Shao JY
Int J Cancer; 2009 Oct; 125(8):1832-41. PubMed ID: 19582878
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of PLCE1 expression in upper gastrointestinal cancer: a systematic review and meta-analysis.
Cui XB; Peng H; Li S; Li TT; Liu CX; Zhang SM; Jin TT; Hu JM; Jiang JF; Liang WH; Li N; Li L; Chen YZ; Li F
Asian Pac J Cancer Prev; 2014; 15(22):9661-6. PubMed ID: 25520085
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of Caveolin-1 correlate with Akt expression and poor prognosis in NPC patients.
Wang YP; Lin CF; Tsai SC; Tsai CH; Yeh TH
Laryngoscope; 2015 Jul; 125(7):E231-8. PubMed ID: 25877996
[TBL] [Abstract][Full Text] [Related]
38. Association of Vascular Endothelial Growth Factor ( VEGF) Gene Polymorphisms With Gastric Cancer and Its Development, Prognosis, and Survival.
Liu W; Dong Z; Hu R; Wang C
Technol Cancer Res Treat; 2018 Jan; 17():1533034617753810. PubMed ID: 29390928
[TBL] [Abstract][Full Text] [Related]
39. Association of caveolin-1 protein expression with hepatocellular carcinoma: a meta-analysis and literature review.
Zhang Y; Fan W; Wu J; Dong J; Cui Z
Cancer Manag Res; 2019; 11():5113-5122. PubMed ID: 31239768
[No Abstract] [Full Text] [Related]
40. Restoration of caveolin-1 expression suppresses growth, membrane-type-4 metalloproteinase expression and metastasis-associated activities in colon cancer cells.
Nimri L; Barak H; Graeve L; Schwartz B
Mol Carcinog; 2013 Nov; 52(11):859-70. PubMed ID: 22674854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
